# FDA Inspection 1175637 - Xytex Laboratories - July 13, 2022

Source: https://www.keypedia.com/records/fda_inspections/xytex-laboratories/1befea66-cd27-4bd7-9b61-809b53513bd5
Source feed: FDA_Inspections

> FDA Inspection 1175637 for Xytex Laboratories on July 13, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1175637
- Company Name: Xytex Laboratories
- Inspection Date: 2022-07-13
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1245934 - 2024-07-25](https://www.keypedia.com/records/fda_inspections/xytex-laboratories/158eb4d7-7308-4903-9523-a9ecc6feef66)
- [FDA Inspection 1175637 - 2022-07-13](https://www.keypedia.com/records/fda_inspections/xytex-laboratories/f0d9191d-6966-48fd-b78b-2d6758fa7295)
- [FDA Inspection 1175637 - 2022-07-13](https://www.keypedia.com/records/fda_inspections/xytex-laboratories/3fde316b-7589-4675-bf95-71dd50f3c888)

Company: https://www.keypedia.com/companies/xytex-laboratories/684de872-efd7-4927-acee-7103a17ae0db

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d